SAGE

Sage Therapeutic (SAGE)

US
$ 7.790%

Price Chart

Key Statistics

Market Cap
$ 399.52M
P/E Ratio
0.00
Revenue (TTM)
$ 47.4M
Volume
1M
52W High
$ 13.47
52W Low
$ 4.62
Dividend Yield
0.00%
Beta
0.20

Technicals

50-Day MA
7.482
200-Day MA
7.1065
52 Week High
13.47
52 Week Low
4.62

About SAGE

Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines.

Employees
353
Headquarters
Cambridge, MA
CEO
Mr. Barry E. Greene

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg